<DOC>
	<DOC>NCT00912431</DOC>
	<brief_summary>The objectives of this study are to determine the cerebrospinal fluid (CSF) levels of ABT-126 and to examine the effects of ABT-126 on exploratory biomarkers after administration of a single does of ABT-126 in healthy volunteers.</brief_summary>
	<brief_title>Pharmacokinetic and Exploratory Biomarker Study of ABT-126 in Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy male or female subjects between 18 and 50 years of age History of bleeding disorders or Deep Vein Thrombosis History of spinal surgery History of migraine headaches, or other types of headaches occuring more than 2 times per month, or history of spinal disc disease, or chronic, significant low back pain</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Healthy Volunteers</keyword>
</DOC>